Gana Misra
By Gana Misra•CEO, Finrep
Mon Sep 28 2026

Section 16 Exemptions: The Complete 2026 Reference Guide

Share
Section 16 Exemptions: The Complete 2026 Reference Guide

Section 16 Exemptions: The Complete 2026 Reference Guide

Section 16 exemptions are the provisions that prevent routine compensatory transactions from triggering short-swing profit liability or reporting obligations that Congress never intended to capture. Without them, every RSU vesting, stock option grant, ESPP purchase, and 401(k) fund reallocation would expose executives to disgorgement claims. Understanding which exemption applies to which transaction, and what conditions must be satisfied, is the practical core of Section 16 compliance.

This guide explains what section 16 exemptions are, why they exist, and how each major exemption works. For step-by-step Form 4 mechanics on equity awards, see Section 16 Reporting for Equity Awards. For the FPI-specific exemption, see Foreign Private Issuer Section 16 Exemption.

Key takeaway: An exemption from Section 16(b) disgorgement and an exemption from Section 16(a) reporting are not the same thing. Many transactions are exempt from disgorgement but still require a Form 4 filing within two business days. Confusing the two is the single most common compliance error.

What Is Section 16 and Who Does It Apply To?

Section 16 of the Securities Exchange Act of 1934 (15 U.S.C. § 78p) imposes three distinct obligations on insiders of public companies: (1) reporting holdings and transactions on Forms 3, 4, and 5 under Section 16(a); (2) disgorging short-swing profits to the issuer under Section 16(b); and (3) a prohibition on short sales under Section 16(c).

"Insiders" for these purposes means:

  • Directors of the issuer
  • Officers as defined in Rule 16a-1(f), the president, principal financial officer, principal accounting officer (or controller), any vice president in charge of a principal business unit, division, or function, any other officer who performs a policy-making function, and any person who performs similar policy-making functions. This definition is narrower than corporate law: a regional VP or assistant secretary typically does not qualify unless they perform a policy-making function.
  • Beneficial owners of more than 10% of any registered class of equity securities, measured at the time of the transaction, not just at the start of a period.

Companies must affirmatively identify which employees are officers for Section 16 purposes. Over-inclusion creates unnecessary compliance burdens; under-inclusion creates enforcement exposure.

The 10% Owner Nuance

For 10% beneficial owners, Section 16 applies only to the class of equity securities that triggers the threshold, not other classes. And critically, the purchase that takes an owner above 10% is not itself subject to Section 16(b) disgorgement, only subsequent transactions are. This rule comes from the Supreme Court's 1976 decision in Foremost-McKesson, Inc. v. Provident Securities Co.

Why Section 16 Exemptions Exist

The short-swing profit rule under Section 16(b) is strict liability. Intent to profit is irrelevant. Any profit from a purchase and sale (or sale and purchase) of the issuer's equity securities within any six-month window is recoverable by the issuer, calculated using the "lowest purchase/highest sale" matching method, not FIFO or specific identification. This methodology can produce a disgorgement amount that exceeds the insider's actual economic gain.

The enforcement mechanism makes this consequential even for technical violations. Section 16(b) suits can be brought by the issuer or, if the issuer fails to sue within 60 days of a shareholder demand, by any shareholder in a derivative action. A cottage industry of plaintiffs' attorneys monitors Form 4 filings specifically to identify disgorgement claims. The statute of limitations is two years from the date the profit was realized.

Without exemptions, the strict liability rule would sweep in transactions that Congress never intended to target: compensatory equity grants, RSU vestings, tax withholding share surrenders, ESPP purchases, and 401(k) reallocations. The SEC has promulgated an extensive exemptive framework under Rules 16a-1 through 16b-8 to carve these out.

The Critical Distinction: Section 16(a) Exemptions vs. Section 16(b) Exemptions

This is where most compliance teams go wrong.

A transaction exempt from Section 16(b) disgorgement is not automatically exempt from Section 16(a) reporting. The two exemption frameworks operate independently. Under Rule 16a-3(f) and (g), transactions exempt from Section 16(b) under Rule 16b-3 still carry reporting obligations:

  • Acquisitions exempt under the board/committee approval condition (Rule 16b-3(d)(1)) or the shareholder approval condition (Rule 16b-3(d)(2)): must be reported on Form 4 within two business days.
  • Acquisitions exempt under the six-month hold condition (Rule 16b-3(d)(3)): the insider may elect to report on Form 5 (within 45 days after fiscal year end) rather than Form 4.

The reverse also exists: Rule 16a-10 provides that any transaction exempt from Section 16(a) reporting is also exempt from Section 16(b), but this is a one-way door. Exempt from reporting does not always mean exempt from disgorgement.

TransactionExempt from 16(b) disgorgement?Reportable under 16(a)?Form
RSU grant (board-approved)Yes, Rule 16b-3(d)(1)YesForm 4, within 2 business days
RSU grant (six-month hold)Yes, Rule 16b-3(d)(3)Yes, but deferredForm 5, within 45 days of FY end
Tax withholding share surrender (board-approved)Yes, Rule 16b-3(e)YesForm 4, within 2 business days
ESPP purchase (qualifying plan)Yes, Rule 16b-3(c)YesForm 4, within 2 business days
Bona fide giftYes, Rule 16b-5YesForm 4 or Form 5
Open-market saleNo exemption availableYesForm 4, within 2 business days
Small acquisition under $10,000No (Rule 16a-6 is a reporting exemption only)DeferredForm 5, within 45 days of FY end
Merger exchange (Rule 16b-7 conditions met)YesYesForm 4, within 2 business days

Rule 16b-3: The Exemption That Matters Most

Rule 16b-3 is the operational heart of Section 16 compliance for any company with an equity compensation program. It exempts transactions between the issuer and its officers or directors involving issuer equity securities from Section 16(b) liability, provided the applicable conditions are met.

As the rule states: "A transaction between the issuer (including an employee benefit plan sponsored by the issuer) and an officer or director of the issuer that involves issuer equity securities shall be exempt from section 16(b) of the Act if the transaction satisfies the applicable conditions set forth in this section."

Acquisitions from the Issuer: Three Alternative Conditions (Rule 16b-3(d))

For grants, awards, and other acquisitions from the issuer, any one of three conditions satisfies the exemption:

  1. Board or Non-Employee Director committee approval: The transaction is approved by the full board or a committee composed solely of two or more Non-Employee Directors.
  2. Shareholder approval: The transaction is approved or ratified by a majority shareholder vote, with ratification occurring no later than the next annual meeting.
  3. Six-month hold: The insider holds the acquired equity securities for at least six months following the acquisition date. For derivative securities, six months must elapse from acquisition to disposition of the derivative or its underlying equity security.

Conditions (1) and (2) require Form 4 reporting within two business days. Condition (3) permits deferral to Form 5.

Dispositions to the Issuer: Rule 16b-3(e)

Dispositions to the issuer, including tax withholding share surrenders (net settlement of RSUs or options) and company share repurchases from insiders, are exempt if the terms are approved in advance by the board or a Non-Employee Director committee, or by shareholder vote. This exemption is ubiquitous in practice because net settlement of RSUs is standard at virtually every public company.

Tax-Conditioned Plans: Rule 16b-3(c)

Transactions under qualified plans (401(k) plans meeting IRC sections 410 and 401(a)(26)), excess benefit plans, and stock purchase plans (ESPPs meeting IRC section 423) are exempt without any additional conditions, except for Discretionary Transactions.

A Discretionary Transaction is a volitional intra-plan transfer involving an issuer equity securities fund, or a cash distribution funded by a volitional disposition of issuer equity securities. Discretionary Transactions within tax-conditioned plans are exempt only if the election is made at least six months after the most recent opposite-direction election (e.g., six months after the last acquisition election if the current transaction is a disposition). This six-month inter-election requirement is separate from the general six-month short-swing profit window.

The Non-Employee Director Definition: A Hidden Trap

The Non-Employee Director definition under Rule 16b-3(b)(3) is stricter than stock exchange independence standards. A director can be "independent" under NYSE or Nasdaq listing rules and still fail the Non-Employee Director test, invalidating the board approval exemption for every transaction the committee approved.

A Non-Employee Director must satisfy all three conditions:

  • Not currently an officer or employee of the issuer or its parent or subsidiary
  • Does not receive compensation from the issuer for services as a consultant or in any other capacity other than as a director, except amounts below the Item 404(a) disclosure threshold, currently $120,000
  • Does not have an interest in any other transaction requiring Item 404(a) disclosure

A director who receives $150,000 in consulting fees from the issuer fails the test, even if they are otherwise independent under exchange rules. SEC no-action letters have addressed edge cases, including whether a paid advisor to the company can qualify, but the staff's position has generally been strict.

The Board Approval Trap: Plans vs. Specific Transactions

This is the most frequently misunderstood aspect of Rule 16b-3, and the one most likely to produce an inadvertent disgorgement exposure.

The rule's note to paragraphs (d)(1), (d)(2), and (e) states explicitly:

"The approval conditions of paragraphs (d)(1), (d)(2) and (e) of this section require the approval of each specific transaction, and are not satisfied by approval of a plan in its entirety except for the approval of a plan pursuant to which the terms and conditions of each transaction are fixed in advance, such as a formula plan."

In plain terms: approving an omnibus equity plan at the annual shareholder meeting does not satisfy Rule 16b-3 for individual grants made under that plan. Each discretionary grant to an officer or director requires its own board or Non-Employee Director committee approval. The exception is a formula plan where all material terms (amount, price, timing) are fixed in advance, in that case, plan-level approval suffices.

Worked example: A company adopts an omnibus equity plan approved by shareholders. The compensation committee (composed of three Non-Employee Directors) then grants 50,000 RSUs to the CFO at its quarterly meeting. The committee's approval of that specific grant satisfies Rule 16b-3(d)(1). If the committee had only approved the plan at the prior year's meeting and made no specific grant approval, the exemption would not apply.

Rule 16b-5: Bona Fide Gifts and Inheritances

Rule 16b-5 exempts bona fide gifts and inheritances from Section 16(b) short-swing profit liability. A gift is not a "purchase" or "sale" for disgorgement purposes.

The reporting obligation, however, remains. Gifts by insiders must be reported under Section 16(a), either on Form 4 within two business days or, at the insider's election, on Form 5 within 45 days after fiscal year end. The SEC confirmed this in its 1996 rulemaking (Release No. 34-37260). Many compliance teams assume that because a gift is exempt from disgorgement, it requires no reporting. That assumption is wrong.

Rule 16b-6: Derivative Securities

Rule 16b-6 addresses the treatment of options, warrants, convertible notes, and other derivative securities. The acquisition of a derivative security is treated as a purchase of the underlying equity security for Section 16(b) purposes. The exercise or conversion of a derivative security into the underlying equity is not treated as a new purchase if the derivative was acquired more than six months before exercise or conversion.

For derivative securities that do not satisfy Rule 16b-3 conditions, Rule 16b-6(b) provides a separate exemption for the exercise or conversion itself, subject to its own conditions. For detailed mechanics on how derivative securities interact with Form 4 reporting, see Section 16 Reporting for Derivative Securities.

Rule 16b-7: Mergers, Reclassifications, and Consolidations

Rule 16b-7 exempts transactions in connection with mergers, reclassifications, and consolidations from Section 16(b), provided the acquiring issuer owns at least 85% of the equity securities of the issuer being acquired before the transaction. This threshold is a hard condition, if the acquirer owns 84%, the exemption does not apply.

For M&A transactions involving insider equity, compliance teams should confirm the 85% ownership threshold is met before relying on this exemption. The transaction still requires Form 4 reporting.

Rule 16b-8: Registered Investment Companies

Rule 16b-8 provides a narrow exemption for certain transactions by registered closed-end investment companies, including share repurchases under a repurchase program. This exemption is relevant primarily to closed-end fund governance and has limited application outside that context.

The 2026 FPI Section 16 Exemption

The most significant structural change to the Section 16 exemptions framework in recent years is the conditional exemption for directors and officers of Foreign Private Issuers (FPIs). The Holding Foreign Insiders Accountable Act, enacted December 18, 2025, extended Section 16(a) reporting requirements to FPI directors and officers effective March 18, 2026. The SEC responded with exemptive orders providing relief for FPIs in qualifying jurisdictions.

The March 5, 2026 order named the initial qualifying jurisdictions: Canada, Chile, the European Economic Area, the Republic of Korea, Switzerland, and the United Kingdom. A May 20, 2026 order expanded the list to include Australia, India, and Singapore.

To rely on the exemption, three conditions must all be satisfied:

  1. The FPI is incorporated or organized in a qualifying jurisdiction.
  2. The FPI is subject to a qualifying regulation of that jurisdiction (or, under the mix-and-match rule, of a different qualifying jurisdiction).
  3. The director or officer is individually required to report under the applicable qualifying regulation, and those reports are made publicly available in English within two business days of posting.

The exemption is individual-specific. An FPI may find that some of its officers qualify and others do not, depending on whether each person is subject to reporting under the applicable home-country regulation. FPIs incorporated in a non-qualifying jurisdiction do not qualify, even if their securities are listed in a qualifying jurisdiction and they are subject to that jurisdiction's insider reporting regime.

For a full compliance walkthrough, see Foreign Private Issuer Section 16 Exemption.

How Rule 10b5-1 Plans Interact with Section 16 Exemptions

A Rule 10b5-1 trading plan does not itself create a Section 16(b) exemption. This is a compliance trap that catches teams who assume that because a sale is made under a pre-cleared, SEC-compliant trading plan, it is automatically exempt from short-swing profit liability. It is not.

Open-market sales under a 10b5-1 plan remain subject to the six-month short-swing profit rule. If an insider receives an equity grant in January and sells shares in the open market in April under a 10b5-1 plan, the sale and the grant are within six months of each other. Unless the grant itself is exempt under Rule 16b-3, the insider faces disgorgement exposure on the matched profit.

The 2022 SEC amendments to Rule 10b5-1 (effective February 27, 2023) added a 120-day cooling-off period for officers and directors before trading under a new plan, plus restrictions on multiple overlapping plans and single-trade plans. These timing constraints interact with the six-month window in ways that require careful calendar management. For a full treatment, see 10b5-1 Plan Adoption Requirements.

Clawback Transactions and Section 16(b)

One gap that existing Section 16 resources universally miss: when a company claws back equity compensation from an executive under the SEC's 2022 Dodd-Frank clawback rules (Release No. 33-11126), the clawback is a disposition of issuer equity securities to the issuer. If that disposition is not structured to satisfy Rule 16b-3(e), meaning the terms were approved in advance by the board or a Non-Employee Director committee, the executive faces Section 16(b) liability on top of the clawback itself.

Companies implementing clawback policies should include a standing board or committee pre-approval of clawback transactions in their Section 16 compliance procedures.

Section 16(a) Reporting: The Filing Deadlines

Even where a transaction is exempt from Section 16(b) disgorgement, the reporting clock runs:

  • Form 3 (initial insider statement): within 10 days of becoming a director, officer, or 10% beneficial owner
  • Form 4 (transaction report): within two business days of the transaction date, a deadline shortened from 10 days by the Sarbanes-Oxley Act of 2002
  • Form 5 (annual statement): within 45 days after fiscal year end, covering transactions that were exempt from Form 4 or that the insider failed to timely report

The SEC requires disclosure in the annual proxy statement under Item 405 of Regulation S-K of any director or officer who failed to file a required Section 16 report on time during the most recent fiscal year. This "name and shame" mechanism creates governance and reputational consequences beyond any direct legal liability. The SEC has also brought enforcement actions against both insiders and issuers for systematic Form 4 delinquencies, with civil monetary penalties and cease-and-desist orders.

For a detailed comparison of when each form is required, see Form 3 vs Form 4 vs Form 5.

FAQ

What is the difference between a Section 16(a) exemption and a Section 16(b) exemption? A Section 16(a) exemption eliminates the reporting obligation entirely (no Form 4 or Form 5 required). A Section 16(b) exemption eliminates short-swing profit disgorgement liability. Many transactions are exempt from disgorgement but still reportable on Form 4 within two business days. The two frameworks operate independently.

Does a stock option grant trigger Section 16(b) if the insider sells shares within six months? Not if the grant is exempt under Rule 16b-3. If the compensation committee (composed solely of two or more Non-Employee Directors) approved the specific grant, the acquisition is exempt from Section 16(b) and cannot be matched against a subsequent open-market sale for disgorgement purposes. The open-market sale itself, however, is not exempt.

Is a tax withholding share surrender (net settlement) exempt from Section 16(b)? Yes, under Rule 16b-3(e), provided the terms of the surrender were approved in advance by the board or a Non-Employee Director committee, or by shareholder vote. This is the standard structure for RSU net settlement at most public companies.

Can a director who is independent under NYSE rules still fail the Non-Employee Director test? Yes. The Non-Employee Director definition under Rule 16b-3(b)(3) is stricter. A director who receives more than $120,000 from the issuer for consulting or other non-director services fails the test, even if they satisfy NYSE independence standards. Companies should audit their compensation committee composition against the Rule 16b-3 definition, not just exchange listing standards.

Does approving an equity plan at the annual meeting satisfy Rule 16b-3 for individual grants? Only if the plan is a formula plan where all material terms of each grant are fixed in advance. Discretionary grants under an omnibus equity plan require transaction-by-transaction approval by the board or Non-Employee Director committee.

What happens if the board approval condition under Rule 16b-3 is not met? The transaction is not exempt from Section 16(b). The insider's acquisition can be matched against any open-market sale (or vice versa) within six months, and the resulting profit is recoverable by the issuer or by a shareholder in a derivative action. There is no cure after the fact, the exemption must be satisfied at the time of the transaction.

Are ESPP purchases exempt from Section 16(b)? Yes, automatically, under Rule 16b-3(c), provided the ESPP meets the coverage and participation requirements of IRC section 423. No additional board approval or holding period is required. The purchase is still reportable on Form 4 within two business days.

Run your financial reporting on Finrep